Stay updated on Nivolumab in ER+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in ER+ Breast Cancer Clinical Trial page.
Latest updates to the Nivolumab in ER+ Breast Cancer Clinical Trial page
- Check4 days agoChange DetectedAdded Padova, Italy 35128 and removed Padua, Italy 35128 from the study locations.SummaryDifference0.0%
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedNapoli, Italy, 80131 was replaced with Naples, Italy, 80131 in the study locations.SummaryDifference0.0%
- Check26 days agoChange DetectedRevision updated to v3.5.0; previous revision v3.4.3 was removed.SummaryDifference0.0%
- Check33 days agoChange DetectedRevision tag on the page changed from v3.4.2 to v3.4.3.SummaryDifference0.0%
- Check62 days agoChange DetectedAdded Revision: v3.4.2. Removed the government funding lapse notice and the prior Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check69 days agoChange DetectedA banner about government funding status and NIH operations was added, with links to cc.nih.gov and opm.gov. The page version was updated from v3.4.0 to v3.4.1.SummaryDifference0.1%
Stay in the know with updates to Nivolumab in ER+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in ER+ Breast Cancer Clinical Trial page.